PMPCB Inhibitors

The inhibitors listed above are not direct inhibitors of PMPCB/MPPβ but rather influence mitochondrial function, which could indirectly affect the activity of the mitochondrial processing peptidase beta subunit. PMPCB/MPPβ is integral to the maturation of mitochondrial proteins, and its function is closely tied to overall mitochondrial health and activity. Therefore, compounds that disrupt or modify mitochondrial function can have a downstream impact on MPPβ. Compounds such as Oligomycin A, Antimycin A, and Rotenone target key components of the mitochondrial electron transport chain. By inhibiting ATP synthase, complex I, or other components of the chain, these compounds disrupt the normal function of mitochondria, which could secondarily impact the processing of mitochondrial precursor proteins, a function associated with MPPβ. Such disruptions could potentially lead to a decrease in the efficiency of mitochondrial protein processing.

Other chemicals, like CCCP and Resveratrol, affect mitochondrial dynamics and biogenesis. CCCP acts as an uncoupler of oxidative phosphorylation, disrupting the mitochondrial membrane potential, which is crucial for numerous mitochondrial processes. Resveratrol is known to influence mitochondrial biogenesis and has been studied for its role in promoting mitochondrial health, which could indirectly impact MPPβ function. Furthermore, compounds like Metformin and Rapamycin, which are known for their effects on metabolic pathways, also influence mitochondrial function. Metformin's action on mitochondrial complex I can indirectly affect mitochondrial protein processing, while Rapamycin's inhibition of mTOR signaling can impact mitochondrial biogenesis and health, potentially influencing MPPβ activity.